Latest Capital Management News

Charter Hall Social Infrastructure REIT (CQE) reported a robust half-year performance with a 51.6% jump in statutory profit and upgraded its FY26 distribution guidance, underpinned by strategic acquisitions and refinancing.

Black Cat Syndicate has completed a strategic acquisition of tenements adjacent to its Lakewood facility, significantly extending tailings storage capacity and paving the way for increased gold production.

Apiam Animal Health shareholders have overwhelmingly approved the proposed acquisition by Adamantem Capital-controlled entities, clearing a critical hurdle for the $500 million deal.

PMET Resources has delivered a positive feasibility study for its flagship Shaakichiuwaanaan lithium project, announcing a maiden mineral reserve and advancing exploration and corporate initiatives. The company also acquired the adjacent Pikwa Property and reported strong drilling results, maintaining a solid cash position.

Ryman Healthcare has unveiled a refreshed strategy focused on growing recurring earnings and optimising its portfolio, targeting a $150 million sustainable cash flow improvement and $500 million cash release by FY29. The company plans to resume dividends from FY28, underpinned by a resilient balance sheet and disciplined capital management.

Credit Corp delivers steady H1 FY26 results with robust US collections and record lending volumes, while pursuing a strategic acquisition to boost its consumer finance footprint.

Credit Corp Group Limited reported a steady half-year profit with a 4% revenue rise, driven by strong US collections and record lending volumes, while advancing its UK presence through a strategic acquisition.

WIN Metals Ltd has launched a prospectus offering up to 78.57 million free attaching options to recent placement participants and its Executive Chairman, aiming to remove trading restrictions and enable market liquidity. The offer follows a $5.5 million capital raise and comes amid ongoing litigation risks.

Arcadia Minerals has secured a binding term sheet with Hongkong Xinhai Mining Services, granting Xinhai an exclusive option to advance the Swanson Tantalum Project in Namibia towards production through a strategic partnership and investment.

PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.

PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.

ResMed Inc. reported robust financial results for Q2 FY2026, driven by strong demand in its Sleep and Breathing Health and Residential Care Software segments. The company also navigates ongoing patent litigation while maintaining solid liquidity and shareholder returns.